uniQure (QURE) Long-Term Investments (2022 - 2026)
uniQure's (QURE) quarterly Long-Term Investments came in at $30.2 million in Q1 2026, up 6.64% year-on-year from $28.3 million in Q1 2025, and little changed quarter-over-quarter from $30.2 million in Q4 2025.
uniQure (QURE) Long-Term Investments (2022 - 2026) Analysis & Trends
uniQure's Long-Term Investments history runs 5 years deep, the most recent figure standing at $30.2 million for Q1 2026.
- On a quarterly basis, Long-Term Investments rose 6.64% year-over-year to $30.2 million in Q1 2026; TTM through Mar 2026 was $30.2 million, a 6.64% increase from a year earlier, with the FY2025 full-year figure at $30.2 million, up 10.1% from the prior year.
- Long-Term Investments held at $30.2 million in Q1 2026 per QURE's latest filing, from $30.2 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $40.0 million in Q4 2022 and bottomed at $2.2 million in Q4 2023.
- The 5-year median for Long-Term Investments is $29.7 million (2025), against an average of $27.4 million.
- Across the five-year window, Long-Term Investments slumped 94.55% in 2023 and jumped 1160.39% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $40.0 million in 2022, then slumped by 94.55% to $2.2 million in 2023, then soared by 1160.39% to $27.5 million in 2024, then gained by 10.1% to $30.2 million in 2025, then slipped by 0.29% to $30.2 million in 2026.
- Per Business Quant, the three latest QURE Long-Term Investments figures stand at $30.2 million (Q1 2026), $30.2 million (Q4 2025), and $30.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 22.17 Mn |
| 10 | uniQure | 2.43 Bn | 2.43 Bn | 3.34 Mn | 30.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.15 Mn |
| Dec 31, 2025 | 30.24 Mn |
| Sep 30, 2025 | 29.97 Mn |
| Jun 30, 2025 | 29.74 Mn |
| Mar 31, 2025 | 28.27 Mn |
| Dec 31, 2024 | 27.46 Mn |
| Sep 30, 2024 | 28.26 Mn |
| Dec 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 39.98 Mn |